Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develo...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

OfficialStocktwitsUser Mar. 20 at 8:07 PM

$DRUG RSI: 28.19, MACD: -2.8499 Vol: 6.21, MA20: 78.55, MA50: 81.08 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

TheRealShortSqueezy Mar. 20 at 4:57 PM

Patience Wins Don’t give up. Not when it’s uncomfortable. Not when progress is slow. Not when no one is watching. Rest if you need to. Small caps market might now be looking hot but there are setups everyday that you could benefit from. Today, I closed $AZTR and it paid off from a $0.275 entry to fully out at $0.35! Market will turn around after this dip and there will be new themes in small caps. $WOLF $DFDV $NXTT $DRUG

0 · Reply

BobJohnBuoy666 Mar. 20 at 3:52 PM

$HELP they are signaling to be bought out. The acquisition angle has always been my reason for investing here. Brand update, large cash position, new CEO, ex-Pfizer exec on board, suspicious drop on decent data (similar to CMPS last year), some evidence of dark pool accumulation, suspiciously low volume despite normal float size suggesting that large holders are just holding and not actively trading. Obviously completely different situations but I am reminded of $DRUG from a few years ago. Could happen, might now, I am positioned extremely aggressively for if it does.

0 · Reply

Bazzzigar Mar. 18 at 9:09 PM

$DRUG

0 · Reply

Shaz1985777 Mar. 18 at 4:38 PM

I feel like $AIM will short squeeze like $DRUG 🔥

0 · Reply

ironic_username Mar. 17 at 8:34 PM

$SWMR Perfect setup, timing and market context. Think multi-day runners like $DRUG, $SMX and $SBET. $100+ coming.

0 · Reply

Trader1141 Mar. 17 at 12:08 PM

$IBRX $CING $DRUG $MNKD

0 · Reply

Trader1141 Mar. 13 at 2:46 PM

$AIFF ADHD news always hot and tend to blow up $DRUG $AMTX $SOS $IMUX

0 · Reply

Shroomm Mar. 11 at 7:04 PM

$DRUG who seen that 20k buy?

0 · Reply

JustAguysOpinion Mar. 10 at 6:02 PM

$TNXP has a awesome pipeline, news and future but what's even more awesome is what it has in common with 2024 $DRUG $ALT and $VKTX those 2.5 million shorts sitting on a 12.8 million float. After all the recent institutions upping ownership leaves less than 9m for retail. Liquidity drying up. Once the right groups see this it will do what those 3 did. Not financial advice just a opinion. They are on here spreading FUD because deep down theu know it can and there's a lot of days to cover. Sales increasing better than

1 · Reply

Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript

Wed, 25 Feb 2026 16:30:00 -0500 - 24 days ago

Bright Minds Biosciences to Present at Upcoming Conferences

2026-02-17T11:31:20.000Z - 4 weeks ago

BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News

Fri, 09 Jan 2026 11:56:00 -0500 - 2 months ago

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

2026-01-08T07:57:10.000Z - 2 months ago

Bright Minds Biosciences (DRUG) Prices $175M Public Offering

Wed, 07 Jan 2026 21:33:00 -0500 - 2 months ago

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

Wed, 07 Jan 2026 15:00:21 -0500 - 2 months ago

Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating

2026-01-07T13:05:22.000Z - 2 months ago

Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Tue, 06 Jan 2026 16:00:00 -0500 - 2 months ago

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

2026-01-06T18:31:59.000Z - 2 months ago

BTIG Raises Price Target for Bright Minds Biosciences (DRUG) to $147 | DRUG Stock News

2026-01-06T18:00:09.000Z - 2 months ago

Bright Minds Biosciences Inc BMB-101 Topline data announcement Transcript

Tue, 06 Jan 2026 11:52:33 -0500 - 2 months ago

New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday

2026-01-06T15:07:53.000Z - 2 months ago

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

2026-01-06T13:00:04.000Z - 2 months ago

Bright Minds Biosciences (DRUG) Surges on Successful Trial Results

Tue, 06 Jan 2026 07:16:00 -0500 - 2 months ago

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

2026-01-06T09:04:44.000Z - 2 months ago

Bright Minds To Unveil Topline Results For BMB-101 Phase 2 Trial In Absence Seizures And DEE

Mon, 05 Jan 2026 16:30:00 -0500 - 2 months ago

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

2026-01-02T13:30:17.000Z - 2 months ago

Bright Minds Biosciences (DRUG) Maintains Buy Rating with $80 Price Target | DRUG Stock News

2025-12-30T16:00:54.000Z - 2 months ago

Bright Minds Biosciences (DRUG) Sees Stable Analyst Rating Today | DRUG Stock News

Tue, 25 Nov 2025 16:30:00 -0500 - 4 months ago

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

2025-11-25T14:55:03.000Z - 4 months ago

Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet

2025-11-17T22:29:36.000Z - 4 months ago

Why Bright Minds Biosciences Stock Topped the Market on Monday

Mon, 17 Nov 2025 06:50:00 -0500 - 4 months ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

2025-11-15T01:53:30.000Z - 4 months ago

Sio Capital Management, LLC Reduces Stake in Bright Minds Biosciences Inc

Thu, 06 Nov 2025 06:30:00 -0500 - 4 months ago

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

2025-10-15T12:50:03.000Z - 5 months ago

Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable

2025-09-18T13:55:01.000Z - 6 months ago

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade

2025-09-15T12:33:59.000Z - 6 months ago

Bright Minds Biosciences (DRUG) Maintains 'Buy' Rating with $85 Price Target | DRUG Stock News

2025-09-08T17:54:11.000Z - 6 months ago

Large Patient Population Is Key Driver For Bright Minds' Growth

2025-09-05T10:56:42.000Z - 7 months ago

Bright Minds Biosciences (DRUG) Launches $100 Million ATM Offering

2025-09-05T00:00:00.000Z - 7 months ago

BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

Tue, 20 May 2025 08:00:00 -0400 - 10 months ago

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

Wed, 07 May 2025 16:45:18 -0400 - 11 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

2025-05-07T20:45:18.000Z - 11 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Mon, 28 Apr 2025 08:00:00 -0400 - 11 months ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Wed, 16 Apr 2025 12:09:11 -0400 - 1 year ago

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025

2025-02-15T04:14:47.000Z - 1 year ago

COMMODORE CAPITAL LP's Strategic Acquisition in Bright Minds Biosciences Inc

2025-02-10T20:16:59.000Z - 1 year ago

Sio Capital Management, LLC Acquires Significant Stake in Bright Minds Biosciences Inc

2025-02-07T18:23:53.000Z - 1 year ago

JANUS HENDERSON GROUP PLC Acquires Shares in Bright Minds Biosciences Inc

Sun, 26 Jan 2025 06:32:26 -0500 - 1 year ago

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101

Tue, 07 Jan 2025 06:50:00 -0500 - 1 year ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Wed, 13 Nov 2024 12:59:00 -0500 - 1 year ago

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

Mon, 04 Nov 2024 14:41:00 -0500 - 1 year ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

2024-11-04T16:05:09.000Z - 1 year ago

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

Wed, 30 Oct 2024 01:07:00 -0400 - 1 year ago

Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential

Mon, 28 Oct 2024 08:21:00 -0400 - 1 year ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

2024-10-23T01:06:51.000Z - 1 year ago

Cormorant Asset Management's Strategic Acquisition of Bright Minds Biosciences Shares

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 1 year ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 10:45 AM EDT - 1 year ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 16, 2024, 5:57 AM EDT - 1 year ago

Biotech stock tumbles after unexplained 1,446% gain

Oct 15, 2024, 9:09 PM EDT - 1 year ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 1 year ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 8, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 2 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 3 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 3 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 3 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 3 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 3 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 3 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

OfficialStocktwitsUser Mar. 20 at 8:07 PM

0 · Reply

TheRealShortSqueezy Mar. 20 at 4:57 PM

0 · Reply

BobJohnBuoy666 Mar. 20 at 3:52 PM

0 · Reply

Bazzzigar Mar. 18 at 9:09 PM

$DRUG

0 · Reply

Shaz1985777 Mar. 18 at 4:38 PM

I feel like $AIM will short squeeze like $DRUG 🔥

0 · Reply

ironic_username Mar. 17 at 8:34 PM

$SWMR Perfect setup, timing and market context. Think multi-day runners like $DRUG, $SMX and $SBET. $100+ coming.

0 · Reply

Trader1141 Mar. 17 at 12:08 PM

$IBRX $CING $DRUG $MNKD

0 · Reply

Trader1141 Mar. 13 at 2:46 PM

$AIFF ADHD news always hot and tend to blow up $DRUG $AMTX $SOS $IMUX

0 · Reply

Shroomm Mar. 11 at 7:04 PM

$DRUG who seen that 20k buy?

0 · Reply

JustAguysOpinion Mar. 10 at 6:02 PM

1 · Reply

BillionerOfKing Mar. 7 at 3:03 AM

$DRUG Current Stock Price: $77.11

0 · Reply

Digitalization2026 Mar. 6 at 6:42 PM

$BHAT 👇 🚀 $EDSA $TPET $DRUG $GXAI

0 · Reply

Quantumup Mar. 5 at 4:25 PM

H.C. Wainwright⬆️ $DRUG's PT to $145 , plus⬆️PoS for the absence epilepsy program to 60% and reiterated at a Buy after catching up w/ Bright Minds MGMT. LBPH - HLUBF / HLBBF UCBJY STOK - BIIB $JAZZ $PRAX Here's what H.C. Wainwright said: https://x.com/Quantumup1/status/2029593548509810731?s=20

0 · Reply

Trick2MoneyisHavingSum Mar. 5 at 3:40 PM

$BHAT $QNCX $DRUG we got this

0 · Reply

Dulinho Mar. 5 at 2:17 PM

$DRUG @CaseyLe fyi this ticker is what I saw with oncy earlier

1 · Reply

Barryman1 Mar. 4 at 12:37 PM

$CANF reminds me on my big gains with $DRUG From 3$ to 80$ Same can happen Here 👀🤩📈

0 · Reply

simplifocused Mar. 3 at 4:03 AM

$PHGE Facts are better than sentiment, see potential in PHGE and can set off like $BATL $TPST $DRUG https://tickernerd.com/stock/phge-forecast/ NFA

0 · Reply

DW65 Feb. 27 at 4:53 PM

$LEXX $DRUG How about we have a HKD run!

1 · Reply

honestrick Feb. 27 at 3:54 PM

$DRUG $NVDA Just sell 50 shares and buy $XRTX .Help a guy out ,You never know what they will announce at there webcast in March .

1 · Reply

TheRealStockRocket Feb. 27 at 3:35 PM

$LEXX this can happen...its happend before with $DRUG and several others .

0 · Reply

Digitalization2026 Feb. 26 at 8:24 PM

$BHAT $BRTX $SAFX $DRUG 📌 $BHAT – Keep Perspective In this market we’ve seen low float names print 100% to 2000% in a single session. One candle can change everything when volume hits and shorts rush to cover. That is the nature of microcaps. BHAT sits in that same thin float category, now pivoted to physical gold trading with real 2025 revenue and ~1200kg on balance sheet. Offering priced at $0.20 with close confirmation pending. Catalysts matter. If volume surges, momentum can stack fast. If not, it chops. 🎯 Watch key levels: $0.065 → $0.10 → $0.20 → $0.40+ Microcap volatility cuts both ways. Manage risk. 💎

1 · Reply

Digitalization2026 Feb. 26 at 7:47 PM

📌 $BHAT – Power Hour Setup Approaching power hour, and yes — shorts are pushing hard and noise is loud. In thin-float microcaps, that’s normal. Ignore fake bulls and bears — focus on facts and catalysts. 🪙 BHAT pivoted to physical gold trading with ~1,200kg on the balance sheet and real trading revenue in 2025. The ~$6.4M offering at $0.20/unit is priced but not yet officially confirmed closed — confirmation could shift sentiment. 📆 Upcoming Catalysts: • Offering close news • Gold monetization updates • Earnings/margin commentary • Nasdaq compliance progress • Partnerships/acquisitions 🔥 Similar Moves: Stocks like $GME, $AMC, $SMX , $DRUG have seen big runs from low levels when catalysts, short covering, and volume aligned. 🎯 Price Targets: $0.065–$0.075 → $0.10–$0.15 → $0.20–$0.30 → $0.40+ → $1+ Microcap + thin float = volatility anytime. Watch volume and news. 💎

1 · Reply

Market Cap	679.79M
Revenue (ttm)	0.00
Net Income (ttm)	-8.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	295,700
Avg Vol	140,146
Day's Range	N/A - N/A
Shares Out	9.73M
Stochastic %K	17%
Beta	-6.04
Analysts	Strong Sell
Price Target	$137.60